Reviewing Intelligent Bio Solutions (NASDAQ:INBS) and Basel Medical Group (NASDAQ:BMGL)

Intelligent Bio Solutions (NASDAQ:INBS) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations.

Profitability

This table compares Intelligent Bio Solutions and Basel Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Basel Medical Group	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Intelligent Bio Solutions and Basel Medical Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1	0	0	0	1.00
Basel Medical Group	1	0	0	0	1.00

Insider and Institutional Ownership

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Intelligent Bio Solutions and Basel Medical Group”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05 million	1.91	-$10.57 million	($12.22)	-0.20
Basel Medical Group	$8.90 million	1.38	-$9.50 million	N/A	N/A

Basel Medical Group has higher revenue and earnings than Intelligent Bio Solutions.

Volatility and Risk

Intelligent Bio Solutions has a beta of 4.21, indicating that its share price is 321% more volatile than the S&P 500. Comparatively, Basel Medical Group has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500.

Summary

Basel Medical Group beats Intelligent Bio Solutions on 5 of the 9 factors compared between the two stocks.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.